Application of mass cytometry in the immune microenvironment of breast cancer

被引:0
作者
Shang, Yuefeng [2 ,3 ]
Pang, Yuheng [2 ,3 ]
Liu, Tong [2 ,3 ]
Wang, Wenjing [1 ]
机构
[1] Capital Med Univ, Beijing YouAn Hosp, Beijing Inst Hepatol, 8 Xi Tou Tiao,Youanmen Wai, Beijing 100069, Peoples R China
[2] Harbin Med Univ, Tumor Hosp, Dept Radiat Oncol, Harbin, Heilongjiang, Peoples R China
[3] Harbin Med Univ, Tumor Hosp, Dept Breast Surg, Harbin, Heilongjiang, Peoples R China
基金
中国国家自然科学基金;
关键词
Breast cancer; Mass cytometry; Single-cell proteome; Tumor immune microenvironment; Targeted therapy; DELTA T-CELLS; BLOCKADE; YAP/TAZ; PARP; CHEMOTHERAPY; EXPRESSION; INHIBITORS; INSIGHTS; PATHWAY; COLON;
D O I
10.1007/s12032-025-02770-w
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The rapid development of immunotherapy has shown preliminary clinical efficacy and significant anti-tumor effects in some cancer patients. Although immunotherapy has been approved for breast cancer, some breast cancer patients still do not benefit from it due to issues such as immunotherapy insensitivity and resistance. Mass cytometry, as a mature single-cell proteomic analysis method, with its high-throughput capabilities, has been widely used in the analysis of tumor immune microenvironments and immune cell subpopulations. Using mass cytometry to analyze the immune microenvironment of breast cancer and explore new immunotherapy targets can help improve the current status of breast cancer immunotherapy and develop personalized treatment plans for more patients. This review surveys the recent advancements in analyzing the single-cell components of breast cancer using mass cytometry technology and reviews the immune microenvironment of breast cancer as well as potential targets for immunotherapy. These results provide new insights for the subsequent research of the immune microenvironment of breast cancer and targeted immunotherapy.
引用
收藏
页数:17
相关论文
共 120 条
[1]   Flow cytometry: basic principles and applications [J].
Adan, Aysun ;
Alizada, Gunel ;
Kiraz, Yagmur ;
Baran, Yusuf ;
Nalbant, Ayten .
CRITICAL REVIEWS IN BIOTECHNOLOGY, 2017, 37 (02) :163-176
[2]   Roles of PD-1/PD-L1 Pathway: Signaling, Cancer, and Beyond [J].
Ai, Luoyan ;
Xu, Antao ;
Xu, Jie .
REGULATION OF CANCER IMMUNE CHECKPOINTS: MOLECULAR AND CELLULAR MECHANISMS AND THERAPY, 2020, 1248 :33-59
[3]   Imaging mass cytometry and multiplatform genomics define the phenogenomic landscape of breast cancer [J].
Ali, H. Raza ;
Jackson, Hartland W. ;
Zanotelli, Vito R. T. ;
Danenberg, Esther ;
Fischer, Jana R. ;
Bardwell, Helen ;
Provenzano, Elena ;
Rueda, Oscar M. ;
Chin, Suet-Feung ;
Aparicio, Samuel ;
Caldas, Carlos ;
Bodenmiller, Bernd .
NATURE CANCER, 2020, 1 (02) :163-+
[4]  
Anderson NM, 2020, CURR BIOL, V30, pR921, DOI 10.1016/j.cub.2020.06.081
[5]   Alpelisib for PIK3CA-Mutated, Hormone Receptor-Positive Advanced Breast Cancer [J].
Andre, Fabrice ;
Ciruelos, Eva ;
Rubovszky, Gabor ;
Campone, Mario ;
Loibl, Sibylle ;
Rugo, Hope S. ;
Iwata, Hiroji ;
Conte, Pierfranco ;
Mayer, Ingrid A. ;
Kaufman, Bella ;
Yamashita, Toshinari ;
Lu, Yen-Shen ;
Inoue, Kenichi ;
Takahashi, Masato ;
Papai, Zsuzsanna ;
Longin, Anne-Sophie ;
Mills, David ;
Wilke, Celine ;
Hirawat, Samit ;
Juric, Dejan .
NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (20) :1929-1940
[6]   Cancer stem cell in breast cancer therapeutic resistance [J].
Bai, Xupeng ;
Ni, Jie ;
Beretov, Julia ;
Graham, Peter ;
Li, Yong .
CANCER TREATMENT REVIEWS, 2018, 69 :152-163
[7]   Single Cell Mass Cytometry Revealed the Immunomodulatory Effect of Cisplatin Via Downregulation of Splenic CD44+, IL-17A+MDSCs and Promotion of Circulating IFN-γ plus Myeloid Cells in the 4T1 Metastatic Breast Cancer Model [J].
Balog, Jozsef A. ;
Hackler, Laszlo, Jr. ;
Kovacs, Anita K. ;
Neuperger, Patricia ;
Alfoeldi, Robert ;
Nagy, Lajos I. ;
Puskas, Laszlo G. ;
Szebeni, Gabor J. .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (01)
[8]   Therapeutic targeting of tumour myeloid cells [J].
Barry, Simon T. ;
Gabrilovich, Dmitry I. ;
Sansom, Owen J. ;
Campbell, Andrew D. ;
Morton, Jennifer P. .
NATURE REVIEWS CANCER, 2023, 23 (04) :216-237
[9]  
Batool A, 2024, Drug resistance in cancer: mechanisms and strategies, P31, DOI [10.1007/978-981-97-1666-12, DOI 10.1007/978-981-97-1666-12]
[10]   The technological landscape and applications of single-cell multi-omics [J].
Baysoy, Alev ;
Bai, Zhiliang ;
Satija, Rahul ;
Fan, Rong .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2023, 24 (10) :695-713